Ask AI

From Today to Tomorrow: the Evolving Clinical Role of CELMoD Agents in Multiple Myeloma

This educational program will review the mechanistic rationale and emerging clinical data supporting CELMoD development across the multiple myeloma treatment continuum, with emphasis on evolving efficacy and safety data, ongoing investigations, and practical considerations surrounding treatment sequencing and future clinical integration.

Program Content

Events

Activities

Evolving Clinical Role of CELMoD Agents in Multiple Myeloma
From Today to Tomorrow: the Evolving Clinical Role of CELMoD Agents in Multiple Myeloma
Video
Congratulations: You achieved a completion on 04/09/2022

Released: July 15, 2026